| Company Name: |
GeneTex, Inc. |
| Tel: |
0755-26755892 1-949-553-1900 |
| Email: |
international@genetex.com |
| Company Name: |
NSJ Bioreagents |
| Tel: |
858.663.9055 8586639055 |
| Email: |
NSJBioname@qq.com |
| Company Name: |
Enzo Biochem Inc |
| Tel: |
Enzo Biochem Inc. 13797054060 |
| Email: |
Enzoname@qq.com |
| Company Name: |
Biosynth Ltd |
| Tel: |
18886812933 |
| Email: |
sales@biosynth.com |
|
| Product Name: | PAX3 antibody | | Synonyms: | PAX3 antibody;Mouse Monoclonal PAX3 Antibody | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![PAX3 antibody Structure]() |
| | PAX3 antibody Chemical Properties |
| | PAX3 antibody Usage And Synthesis |
| Source | Rabbit | | Reactivity | Human | | Background | Paired box proteins are a family of transcription factors that play important and diverse roles in animal development. Nine PAX proteins have been described in humans and other mammals. They are defined by the presence of an amino-terminal "paired" domain, consisting of two helix-turn-helix motifs, with DNA binding activity. PAX proteins are classified into four structurally distinct subgroups based on the absence or presence of a carboxy-terminal homeodomain and a central octapeptide region. Subgroup I contains the octapeptide but lacks the homeodomain; subgroup II contains the octapeptide and a truncated homeodomain; subgroup III contains the octapeptide and a complete homeodomain; and subgroup IV contains a complete homeodomain but lacks the octapeptide region. PAX proteins play critically important roles in development by regulating transcriptional networks responsible for embryonic patterning and organogenesis; a subset of PAX proteins also maintain functional importance during postnatal development. Research studies have implicated genetic mutations that result in aberrant expression of PAX genes in a number of cancer subtypes, with members of subgroups II and III identified as potential mediators of tumor progression. | | References | [1] Lang, D. et al. (2007) Biochem Pharmacol 73, 1-14.
[2] Robson, E.J. et al. (2006) Nat Rev Cancer 6, 52-62.
[3] Wang, Q. et al. (2008) J Cell Mol Med 12, 2281-94.
[4] Blake, J.A. et al. (2008) Dev Dyn 237, 2791-803. |
| | PAX3 antibody Preparation Products And Raw materials |
|